The relation of obesity with serum resistin levels in smoker and nonsmokers

Journal of Research in Medical Sciences

Volumn 17, Issue 2, 2012, Pages 119-122

  Gürsoy, Gül ^a   Eşbah, Onur ^a   Kirnap, Nazli Gülsoy ^a   Çetiner, Hacer ^a   Acar, Yaşar ^a   Demirbaş, Berrin ^b   Öztürk, Abidin ^a   Kiliç, Zuhal ^a  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b Mesa Hospital Cankaya   (Turkey)

Author keywords

Obesity; Resistin; Smoking

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; RESISTIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY FAT; BODY HEIGHT; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; OBESITY; POSTPRANDIAL STATE; SMOKING; SYSTOLIC BLOOD PRESSURE; WAIST HIP RATIO;

EID: 84866671519     PISSN: 17351995     EISSN: 17357136     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Hofso D, Uerland T, Hager H, Jenssen T, Bollerslev J, Godang K, et al. Inflammatory mediators in morbidly obese subjects: Associations with glucose abnormalities and changes after oral glucose. Eur J Endocrinol 2009;161:451-8.
2. Bakhai A. Adipokines-targeting a root of cardiometabolic risk. Advertise with Oxford Journals. QJM 2008; 101:767-76.
3. Shah A, Mehta N, Reilly MP. Adipose inflammation, insulin resistance and cardiovascular disease. JPEN J Parenter Enteral Nutr 2008;32:638-44.
4. Steppan CM, Bailey ST, Bhat S, Brown EJ, Naerjee RR, Wright CM, et al. The hormone resistin links obsity to diabetes. Nature 2001;409:307-12.
5. Kim KH, Lee K, Moon YS, Sul HS. A cysteine rich adipose tissue specific secretory factor inhibits adipocyte differentiation. J Biol Chem 2001;276:11252-6.
6. Holcomb IN, Kabakoff RC, Chan B. FIZZI, a novel cysteinerich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J 2000;19:4046-55.
7. Al-Harithy RN, Al-Ghamdi S. Serum resistin, adiposity and insulin. resistance in Saudi women with type 2 diabetes mellitus. Ann Saudi Med 2005;25:83-7.
8. Savage DB, Sewter CP, Klenk ES, Segal DG, Vidal-Puig RV, Considine A, et al. Resistin/ Fizz3 expression in relation to obesity and peroxisime proliferator activated receptor gamma action in humans. Diabetes 2001;50:2199-202.
9. Lee JH, Chan JL, Yiannakouris N. Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: Cross-sectional and interventional studies in normal, insulin resistant and diabetic subjects. J Clin Endo Metab 2003;88:4848-56.
10. Vozaro va de Courten et al. High serum rezistin is associated with an increase in adiposity but not worsening of insulin resistance in Pima Indians. Diabetes 2004;53:1279-84.
11. Rea R, Donnolly R. Resistin: An adpocyte derived hormone. Has it a role in diabetes and obesity? Diabetes Obes Metab 2004;6:163-70.
12. Utzschneider KM, Carr DB, Tong J, Wallace TM, Hull RL, Zraika S, et al. Resistin is not associated with insulin sensitivity or the metabolic syndrome in humans. Diabetologia 2005;48:2330-3.
13. Makimura H, Mizuno TM, Bergen H, Mobbs CV. Adiponectin is stimulated by adrenalectomy in ob/ob mice and is highly correlated with resistin mRNA. Am J Physiol Endocrinol Metab 2002;283:E1266-71.
14. Willi C, Bodenmann P, Ghali WA, Faris PD, Cornuz J. Active smoking and the risk of type 2 diabates. JAMA 2007;298:2654-64.
15. Ronemma TR, Ronemma EM, Puukka P, Laakso M. Smking is independently associated with high plasma insulin levels in non diabetic men. Diabetes Care 1996;19:1229-32.
16. Nakashita Y, Nakamura M, Kitamura A, Kiyama M, Ishikawa Y, Mikami H. Relationships of cigarette smoking and alcohol consumption to metabolic syndrome in Japanese men. J Epidemiol 2010;20:391-7.
17. Al Mutairi SS, Mojiminiyi OA, Shihab-Eldeen AA, Al Sharafi A, Abdella N. Effect of smoking habit on circulating adipokines in diabetic and non-diabetic subjects. Ann Nutr Metab 2008;52:329-34.
18. Al-Daghri NM, Al-Attas OS, Hussain T, Sabico S, Bamakhramah A. Altered levels of adypocytokines in Type 2 diabetic cigarette smokers. Diabetes Res Clin Pract 2009;83:e37-9.
19. Zhu Y, Zhang M, Hou X, Lu J, Peng L, Gu H, et al. Cigarette smoking increases risk for incident metabolic syndrome in Chinese men-shanghai diabetes study. Biomed Environ Sci 2011;24:475-82.
20. Massulli M, Riccardi G, Galasso R, Vaccaro O. Relationship between smoking habits and the features of the metabolic syndrome in a non-diabetic population. Nutr Metab Cardiovasc Dis 2006;16:364-70.
21. Janghorbani M, Amini M, Rezvanian H, Gouya MM, Delavari A, Alikhani S, et al. Association of body mass index and abdominal obesity with marital status in adults. Arch Iran Med 2008;11:274-81.
22. Gharipur M, Kelishadi R, Toghianfar N, Tavassoli AA, Khosravi AR, Sajadi F, et al. Socioeconimic Disparities and smoking habits inmetabolic syndrome: Evidence from Isfahan Healthy Heart Program. IRCM J 2011;13:537-43.
23. Albanes D, Jones DY, Micozzi MS, Mattson ME. Associations between smoking and body weight in the US population: Analysis of NHANES II. Am J Public Health 1987;77:439-44.
24. Augustson EM, Wanke KL, Rogers S, Bergen AW, Chaterjee N, Synder K, et al. Predictors of sustained smoking sessation: A prospective analysis of chronic smokers from Alpha-Tocopherol Beta Carotene Cancer Prevention Study. Am J Public Health 2008;98:549-55.
25. Seidell JC. Time trends in obesity: An epidemiolocigal perspective. Horm Metab Res 1997;29:155-8.
26. Shimokata H, Muller DC, Anders R. Studies in the distribution of bodt fat, III: Effects of cigarette smoking. JAMA 1989;261:1169-73.
27. Al Mutairi SS, Mojiminiyi OA, Shihab-Eldeen A, Al Rammah T, Abdella N. Putative roles of circulating resistin in patients with asthma, COPD and cigarette smokers. Dis Markers 2011;31:1-7.
28. Al-Daghri NM, Al-Attas OS, Hussain T, Sabico S, Bamakhramah A. Altered levels of adipocytokines in type 2 diabetic cigarette smokers. Diabetes Res Clin Pract 2009;83:e37-9.
29. Attvall S, Fowelin J, Lager J, Von Schenk H, Smith U. Smoking induces insulin reistance: A potential link with the insulin resistance syndrome. J Intern Med 1997;223:327-32.
30. Farin HM, Abbasi F, Kim SH, Lamendola C, McLaughlin T, Reaven GM. The relationship between insulin resistance and dyslipidemia in cigarette smokers. Diabetes Obesity Metab 2007;9:65-9.
31. Eliason B, Attvall S, Taskinen MR, Smith U. The insulin resistance syndrome in smokers is related to smoking habits. Arterioscler Tromb 1994;14:1946-50.
32. Rimm EB, Chan J, Stampher MJ, Colritz GA, Willet WC. Prospective study of cigarette smoking, alcohol use and the risk of diabetes in men. BMJ 1995;310:555-9.
33. Daniel M, Cargo MD. Association between smoking, insulin resistance and beta cell function in a North-Western First Nation. Diabetes UK. Diabetic Med 2004;21:188-93.
34. Eliason B, Mero N, Taskinen MR, Smith U. The insulin resistance syndrome and post-prandial lipid intolerance in smokers. Atherosclerosis 1997;129:79-88.
35. Benwitz NL. Pharmacological aspects of cigarette smoking and nicotine action. Eng J Med 1988;319:1318-30